Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation

Autor: Nico Gagelmann, Diderik-Jan Eikema, Matthias Stelljes, Dietrich Beelen, Liesbeth de Wreede, Ghulam Mufti, Nina Simone Knelange, Dietger Niederwieser, Lone S. Friis, Gerhard Ehninger, Arnon Nagler, Ibrahim Yakoub-Agha, Ellen Meijer, Per Ljungman, Johan Maertens, Lothar Kanz, Lucia Lopez-Corral, Arne Brecht, Charles Craddock, Jürgen Finke, Jan J. Cornelissen, Paolo Bernasconi, Patrice Chevallier, Jorge Sierra, Marie Robin, Nicolaus Kröger

Publikováno v: Haematologica, Vol 104, Iss 5 (2019)

The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation regi

Externí odkaz: https://doaj.org/article/e6a222a8f1004b0f88fbe3dcafbf42d0

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

Autor: Nico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, Linda Koster, Hareth Nahi, Anne-Marie Stoppa, Tamás Masszi, Denis Caillot, Stig Lenhoff, Miklos Udvardy, Charles Crawley, William Arcese, Clara Mariette, Ann Hunter, Xavier Leleu, Martin Schipperus, Michel Delforge, Pietro Pioltelli, John A. Snowden, Maija Itälä-Remes, Maurizio Musso, Anja van Biezen, Laurent Garderet, Nicolaus Kröger

Publikováno v: Haematologica, Vol 103, Iss 5 (2018)

We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first-line autologous stem cell transplantation. We identified 3744 adult myeloma patients who received up-front single (n=3391) o

Externí odkaz: https://doaj.org/article/06bc03d29827406b9491d6f70c0b97bf

P-277: Carfilzomib, lenalidomide and dexamethasone followed by a second autologous hematopoietic cell transplantation is an effective strategy in first-relapsed multiple myeloma

Autor: Remi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas Schaap, Concepcion Herrera Arroyo, Christine Schuermans, Wolfgang Bethge, Monika Engelhardt, Jürgen Kuball, Mariagrazia Michieli, Natalie Schub, Keith M.O. Wilson, Jean Henri Bourhis, María-Victoria Mateos, Neil Rabin, Edgar Jost, Nicolaus Kröger, José Mª Moraleda, Simona Sica, Patrick J. Hayden, Meral Beksac, Stefan Schönland, Salomon Manier

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S190

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::954b92173febec9a63ebd148e5e0c6c2
https://doi.org/10.1016/s2152-2650(22)00607-3

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

Autor: Laurent Garderet, Samo Zver, Stig Lenhoff, Claude-Eric Bulabois, Jakob Passweg, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Denis Caillot, Guido Kobbe, Nicola Mordini, Pietro Pioltelli, Alessandro Rambaldi, Xavier Poiré, Patrice Chevallier, Nicolaus Kröger, Murray Martin, Michel Delforge, Liesbeth C. de Wreede, Linda Koster, Xavier Leleu, Per Ljungman, Simona Iacobelli, Stefan Schönland, Mark Ringhoffer, Diderik-Jan Eikema, Péter Remémyi, Didier Blaise, Nico Gagelmann

Publikováno v: Bone marrow transplantation, Vol. 56, no.1, p. 210-217 (2021)
Bone Marrow Transplantation. NATURE PUBLISHING GROUP
Bone Marrow Transplantation

We analyzed newly diagnosed multiple myeloma patients with del(17p) and/or t(4;14) undergoing either upfront single autologous (auto), tandem autologous (auto-auto) or tandem autologous/reduced-intensity allogeneic (auto-allo) stem cell transplantati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246b80e80ddb45a4b8188a229713c5d6
https://hdl.handle.net/1887/3182219

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Autor: Liesbeth C. de Wreede, Jürgen Finke, Diderik Jan Eikema, Jorge Sierra, Yves Beguin, Gérard Socié, Achilles Anagnostopoulos, Zübeyde Nur Özkurt, Anja van Biezen, Tobias Gedde-Dahl, Guido Kobbe, Maija Itälä-Remes, Dietger Niederwieser, Linda Koster, Marie Robin, Theo de Witte, Pavel Jindra, Johan Maertens, Dimitris Ziagkos, Eline M. P. Cremers, Nicolaus Kröger, Dietrich W. Beelen, Arnon Nagler, Per Ljungman

Publikováno v: Cremers, E M P, de Witte, T, de Wreede, L, Eikema, D-J, Koster, L, van Biezen, A, Finke, J R, Socié, G, Beelen, D, Maertens, J, Nagler, A, Kobbe, G, Ziagkos, D, Itälä-Remes, M, Gedde-Dahl, T, Sierra, J, Niederwieser, D, Ljungman, P, Beguin, Y, Ozkurt, Z N, Anagnostopoulos, A, Jindra, P, Robin, M & Kröger, N 2019, ' A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation * ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2404-2414 . https://doi.org/10.1080/10428194.2019.1594215
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare

Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. This prospective non-interventional study evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea9ef9c193ca24bcb26cc9ed8891a9e1
https://pubmed.ncbi.nlm.nih.gov/30997844